MFC Price Prediction Next Week
Technical Analysis: MFC's stock has shown significant volatility in recent trading sessions. The stock closed at $30.36 on Friday, experiencing a -4.59% decline during regular market hours, though showing signs of recovery with a +2.11% gain in post-market trading.
Price Targets & Analyst Consensus: Recent analyst updates show strong bullish sentiment:
- RBC Capital raised target from C$49 to C$51 with Outperform rating
- BMO Capital increased target from C$50 to C$52 with Outperform rating
- CIBC raised target from C$47 to C$48 with Neutral rating
- DBS maintains Buy rating with HK$280 target
Insider Sentiment & Market Dynamics: Corporate insider sentiment has turned negative, with increased selling activity compared to earlier periods. This contrasts with the generally positive analyst outlook.
Price Prediction for Next Week: Based on technical indicators and recent price action:
- Support level: $30.31 (Friday's low)
- Resistance level: $31.90 (Friday's high)
Expected price range for next week: $30.80 - $31.50
- Base case target: $31.20 (3% upside from current price)
- Bullish case: Could test $31.90 if market sentiment improves
- Bearish case: Might retest $30.31 support level
Trading Recommendation: BUY Rationale:
- Strong analyst upgrades with multiple price target increases
- Post-market recovery indicates potential short-term bottom
- Technical indicators suggest oversold conditions after Friday's decline
- Entry point: Current price ($30.36)
- Stop loss: $30.00
- Take profit: $31.50
MFC Similar Chart Price Prediction
The price of MFC is predicted to go up 100%, based on the high correlation periods with DTST. The similarity of these two price pattern on the periods is 91.22%.
MFC
DTST
Up: 100%Similarity: 91.22%
MFC Revenue Forecast
MFC EPS Forecast
MFC FAQs
What is bull’s view on MFC?
What is bear's view on MFC?
What is MFC revenue forecast for next quarter？
What is MFC eps forecast for next quarter？
MFC VS S&P500
Manulife could achieve strong growth in Asia within the next few years, driving overall top-line growth and improving geographic diversification.
Manulife has clearly laid out plans to reduce exposure to riskier products like long-term care insurance and variable annuities and increase exposure to high-potential businesses like behavioral insurance, asset management, and Asia.
The company will be a net beneficiary of rising interest rates in the long run as it can reinvest its maturing fixed-income securities at a higher yield.
MFC Analyst's Forecast
Darko Mihelic
RBC Capital
Buy
2025-02-21
Price Target
$49 → $51
Upside
+67.98%
RBC Capital analyst Darko Mihelic raised the firm's price target on Manulife Financial to C$51 from C$49 and keeps an Outperform rating on the shares.
